Enzo Biochem Inc Asset Turnover Ratio (ENZ), as of third quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Enzo Biochem Inc  (NYSE: ENZ)
 

Enzo Biochem Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Enzo Biochem Inc asset turnover ratio, the ability of Enzo Biochem Inc's assets to generate revenue in the third quarter 2025, increased sequentially to 0.35 in the third quarter (Apr 30 2025), ENZ's balance sheet remain strong.

Within sector 24 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Third Quarter 2025 compared to the preceding quarter from 2557 to 2594.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ENZ Asset Turnover Ratio (Apr 30 2025)
III. Quarter		 (Jan 31 2025)
II. Quarter		 (Oct 31 2024)
I. Quarter		 (Jul 31 2024)
IV. Quarter		 (Apr 30 2024)
III. Quarter
Y / Y Asset Change -31.64 % -34.33 % -28.13 % -6.23 % 52.43 %
Y / Y Revenue Change -20.19 % -14.25 % -20.41 % - -50.2 %
Asset Turnover Ratio (TTM) 0.35 0.34 0.32 0.31 0.05
ENZ's Total Ranking # 2594 # 2557 # 0 # #
Seq. Asset Change -1.56 % -12.99 % -33.82 % 20.6 % -5.42 %
Seq. Revenue Change -12.71 % 18.04 % -17.45 % -6.18 % -6.21 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 25
Healthcare Sector # 362
Overall Market # 2594

Asset Turnover Ratio Statistics
High Average Low
1.61 -12.89 -220.58
(Jan 31 2014)   (Jul 31 2023)




ENZ Company Profile • Back to ENZ Efficiency Comparisons • Compare ENZ Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Apr 30 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Apr 30 2025 Assets at quarter ending Apr 30 2025
Electromed Inc   1.19 $ 60.984  Millions$ 51.459  Millions
Idexx Laboratories Inc  1.18 $ 3,931.236  Millions$ 3,318.191  Millions
Nuo Therapeutics Inc   1.18 $ 1.615  Millions$ 1.369  Millions
Mettler toledo International Inc   1.17 $ 3,830.156  Millions$ 3,260.918  Millions
Nuwellis Inc   1.17 $ 8.709  Millions$ 7.447  Millions
Precipio inc   1.16 $ 20.029  Millions$ 17.263  Millions
Pro dex Inc   1.15 $ 64.124  Millions$ 55.884  Millions
Cytomx Therapeutics Inc   1.14 $ 147.557  Millions$ 129.308  Millions
Vaso Corporation  1.14 $ 87.491  Millions$ 76.715  Millions
Dynatronics Corporation  1.13 $ 28.427  Millions$ 25.055  Millions
Natera Inc   1.13 $ 1,831.000  Millions$ 1,625.259  Millions
Trisalus Life Sciences Inc   1.12 $ 31.543  Millions$ 28.126  Millions
Phibro Animal Health Corporation  1.12 $ 1,190.083  Millions$ 1,061.979  Millions
The Pennant Group Inc   1.12 $ 748.167  Millions$ 668.093  Millions
Inogen Inc   1.11 $ 339.960  Millions$ 304.922  Millions
Puma Biotechnology Inc   1.11 $ 232.709  Millions$ 208.809  Millions
Docgo Inc   1.11 $ 520.501  Millions$ 467.116  Millions
Universal Health Services Inc   1.11 $ 16,084.073  Millions$ 14,442.614  Millions
Ensysce Biosciences Inc   1.11 $ 6.224  Millions$ 5.597  Millions
Amedisys Inc  1.11 $ 2,371.691  Millions$ 2,144.943  Millions
Inspire Medical Systems inc   1.10 $ 839.173  Millions$ 765.944  Millions
Nrc Health  1.09 $ 141.298  Millions$ 129.653  Millions
Medpace Holdings Inc   1.08 $ 2,156.580  Millions$ 2,000.586  Millions
Reshape Lifesciences Inc  1.07 $ 6.226  Millions$ 5.821  Millions
Sanara Medtech Inc   1.06 $ 91.485  Millions$ 86.600  Millions
Sonoma Pharmaceuticals Inc   1.04 $ 14.288  Millions$ 13.680  Millions
Biocryst Pharmaceuticals Inc   1.04 $ 503.485  Millions$ 483.535  Millions
Tandem Diabetes Care Inc   1.04 $ 982.309  Millions$ 946.259  Millions
Adma Biologics Inc   1.04 $ 457.758  Millions$ 441.566  Millions
Cormedix Inc   1.02 $ 82.554  Millions$ 80.547  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.